Evidence map›Paper›PMID 24169943›Full record

ReviewBMJ (Clinical research ed.)2013

Non-publication of large randomized clinical trials: cross sectional analysis.

Christopher W Jones, Lara Handler, Karen E Crowell, Lukas G Keil, Mark A Weaver, Timothy F Platts-Mills

Abstract readReview
In one paragraph

Review in BMJ (Clinical research ed.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 13 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 13 syntheses or guidelines pooled it.

  1. Pooled it
  2. Time to publication for results of clinical trials.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Industry sponsorship and research outcome.The Cochrane database of systematic reviews · 2017
    Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Barriers and facilitators to disseminating quality improvement and patient safety research: a scoping review.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2025
    Article
  19. The meta-analysis and systematic review mirage: when data synthesis becomes data distortion.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Christopher W JonesDepartment of Emergency Medicine, Cooper Medical School of Rowan University, OneCooper Plaza, Camden, NJ 08103, USA.
Lara Handler
Karen E Crowell
Lukas G Keil
Mark A Weaver
Timothy F Platts-Mills

Funding

UNC Clinical and Translational Science AwardUL1TR000083 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2012 to 2013
$11.6M
UNC Clinical Translation Science Award-K12 Scholars Program (KL2)KL2TR000084 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2012 to 2013
$2.3M
NCATS NIH HHS KL2 TR00084NCATS NIH HHS UL1TR000083
6 · The paper itself

Abstract

objectiveTo estimate the frequency with which results of large randomized clinical trials registered with ClinicalTrials.gov are not available to the public.

designCross sectional analysis

settingTrials with at least 500 participants that were prospectively registered with ClinicalTrials.gov and completed prior to January 2009. DATA SOURCES: PubMed, Google Scholar, and Embase were searched to identify published manuscripts containing trial results. The final literature search occurred in November 2012. Registry entries for unpublished trials were reviewed to determine whether results for these studies were available in the ClinicalTrials.gov results database.

main outcome measuresThe frequency of non-publication of trial results and, among unpublished studies, the frequency with which results are unavailable in the ClinicalTrials.gov database.

resultsOf 585 registered trials, 171 (29%) remained unpublished. These 171 unpublished trials had an estimated total enrollment of 299,763 study participants. The median time between study completion and the final literature search was 60 months for unpublished trials. Non-publication was more common among trials that received industry funding (150/468, 32%) than those that did not (21/117, 18%), P=0.003. Of the 171 unpublished trials, 133 (78%) had no results available in ClinicalTrials.gov.

conclusionsAmong this group of large clinical trials, non-publication of results was common and the availability of results in the ClinicalTrials.gov database was limited. A substantial number of study participants were exposed to the risks of trial participation without the societal benefits that accompany the dissemination of trial results.

Indexed as

Access to InformationCross-Sectional StudiesPublishingRandomized Controlled Trials as TopicRegistriesTime Factors

Identifiers

PMID24169943
PMCPMC3812466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.